Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese proprietary medicine for treating rheumatoid arthritis

An arthritic and proprietary Chinese medicine technology, applied in the fields of plant/algae/fungus/moss ingredients, antipyretics, anti-inflammatory agents, etc.

Inactive Publication Date: 2014-01-15
岳喜杰
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The etiology of this disease is not yet fully understood
At present, there is no effective drug and treatment in Western medicine. Long-term use of non-steroidal anti-inflammatory painkillers can easily damage the spleen and stomach, and only play a temporary role in relieving symptoms. It is easy to relapse after stopping the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese proprietary medicine for treating rheumatoid arthritis
  • Chinese proprietary medicine for treating rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0054] Example 1: Deng Yuzhu, female, 56 years old, from Leizhuang Village, Acheng Town, Yanggu County, went to the doctor in November 2009. The pain in the small joints and knees of both hands lasted for more than 3 months. The patient had no obvious cause before March. The joints and metacarpophalangeal joints were swollen and painful. I didn't pay attention to it. Later, I gradually developed pain in both knees and difficulty in walking. Since the onset of the disease, it has been accompanied by morning stiffness. After about 15 days, the whole body is heavy and sore, and there is no obvious discomfort. It is recommended to check in the hospital and see a doctor For rheumatoid arthritis. Oral medicine of the present invention, every day 3 times, each 4, 15 days is a course for the treatment of, oral 6 courses for the treatment of, joint swelling is not obvious, has no obvious walking disadvantage. After taking 6-7 courses for the treatment of, all symptoms disappeared witho...

example 2

[0055] Example 2: Yang Yuchen, male, 49 years old, a resident of Qiancang Village, Litai Town, Yanggu County, visited the doctor in March 2010. His fingers and wrists were swollen, painful and feverish for about 3 months. The location was humid, resulting in swelling and pain in both wrists, followed by swelling and pain in the fingers, morning stiffness, and gradually swelling and pain in the lower knees and ankle joints, making it difficult to walk. Bored and restless. He once visited a local hospital and was diagnosed with "rheumatoid arthritis" after examination. Oral medicine of the present invention, every day 3 times, each 4, 15 days is a course for the treatment of, oral 7 courses for the treatment of, patient's two fingers, two lower extremity arthralgia swelling disappears, and walking activity is normal. Follow up a case by regular visits to after half a year, all diseases disappear, and disease is fully recovered.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Chinese proprietary medicine for treating rheumatoid arthritis. The Chinese proprietary medicine is characterized by being composed of following high quality traditional Chinese medicine raw materials according to a certain weight ratio: Chinese starjasmine stem, caulis sinomenii, caulis pipers futokadsurae, spatholobus stem, Chinese ivy stem, ligusticum wallichii, alangium lamarchii thwaites, mollissima, Chinese angelica, red sage root, Japanese snailseed root, coix seed, radix astragali, ramulus mori, taxillus, clematis root, buck grass, cassia twig, bighead atractylodes rhizome, achyranthcs bidentata blume, notopterygium root, and Chinese actinidia root; and is prepared through the following steps: first processing six medicinal materials, namely Chinese starjasmine stem, caulis sinomenii, ligusticum wallichii, coix seeds, Chinese actinidia root, and mollissima, into traditional Chinese medicine micro-powder by adopting a micro-powder processing technology, decocting and condensing the other medicinal materials to make into paste, then adding the processed traditional Chinese medicine micro-powder into the condensed paste, stirring, reconciling, making into fine particles, and finally packaging into small capsules for oral use. The Chinese proprietary medicine has the characteristics of prominent curative effect, high cure rate, no pain, no relapse, user-friendliness, low treatment cost, reduction on complication, and little side or toxic effect. It has been testified through clinical application comparative tests that the effective rate is 83.8%, and the cure rate is 45.37%.

Description

Technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and relates to a pharmaceutical composition for treating rheumatoid arthritis, in particular to a Chinese patent medicine for treating rheumatoid arthritis prepared from plant Chinese herbal medicines. Background technique [0002] Rheumatoid arthritis is a multisystemic inflammatory autoimmune disease mainly involving peripheral joints. Its characteristic symptoms are symmetrical and chronic inflammatory lesions of multiple peripheral joints. Clinically, joint swelling and pain, limited mobility, violation of articular cartilage, subchondral bone ligaments and tendons, etc. cause damage to articular cartilage and joint capsule, eventually leading to joint deformity And loss of function, higher disability rate. The etiology of this disease is still not completely clear. At present, there is no effective medicine and treatment in Western medicine. Long-term use of non-steroi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8994A61P29/00A61P19/02
Inventor 岳喜杰
Owner 岳喜杰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products